(2017) conducted targeted sequencing on 11,730 patients with neurodevelopmental disorders and found that ASH1L mutation was in all the patients with intellectual disabilities, two‐thirds of them with autism and two‐thirds with epilepsy, indicating that ASHIL may be involved in a variety of neurodevelopmental disorders. This evidence concerns the gene ASH1L and epilepsy.